chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine administered at 4:30pm. Child awake with high fever and agitated mind for two hours from 1-3am, fever of 101.1. At noon the following day, the fever is 101.2.
Injection (Tdap) 4-14-15 left arm bleed and bruise. 4-14-15 lightheaded dizziness. 4-15-15 aches and joint pain fever (flu like symptoms) fatigue, mild stomach upset, lightheaded dizziness. 4-16-15 Same as 4-15-15. 4-17-15 rash on arm below injection site still fatigue and joint pain discomfort in throat and looked like mild rash- dizziness also arm itching. heart pounding BP 168/98. 4-18-15 rash on arm- joint pain (throat discomfort) lightheaded- dizziness. 4-19-15 headache, arm itching, mild joint discomfort. 4-14-15 thru 4-19-15 treatment IBU- TYLENOL- BENADRYL. 4-19-15 when to doctor- Allergic (serum sickness). Prescribed prednisone 20mg twice a day for 5 days.
LOST HER VOICE; CAN'T TALK SINCE GETTING THE VACCINE; VOICE HAS CHANGED; MADE HER STRESSED OUT; MAKES HER IRRITABLE; EVERY NIGHT SHE CRIES; This spontaneous report received from a patient concerned a 37 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included smoker. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 2021, Laboratory data included: Coronavirus test (NR: not provided) NEGATIVE. On MAR-2021, the subject experienced lost her voice. On MAR-2021, the subject experienced can't talk since getting the vaccine. On MAR-2021, the subject experienced voice has changed. On MAR-2021, the subject experienced made her stressed out. On MAR-2021, the subject experienced makes her irritable. On MAR-2021, the subject experienced every night she cries. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from can't talk since getting the vaccine, lost her voice, voice has changed, made her stressed out, makes her irritable, and every night she cries. This report was non-serious.
Fever 100.7; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the right arm on 20May2021 at 15:30 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. Medical history included ehlers-danlos syndrome, asthma, dysautonomia and latex allergy. The patient had known allergies to biaxin, morphine, codiene and compazine.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included fremanezumab vfrm (AJOVY) and gabapentin (MANUFACTURER UNKNOWN); both for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0171) via an unspecified route of administration in the right arm on 29Apr2021 at 15:30 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21May2021 at 17:30, after second dose COVID-19 vaccine, the patient experienced fever 100.7. On 21May2021 at 17:30 patient underwent lab tests which include body temperature and the result was found to be 100.7 (unit unspecified). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of fever and included treatment with TYLENOL. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event fever 100.7 was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Local swelling/redness at site of injection. 3 days later, developed raised red lesions on legs with c/o headaches and arthralgias.
Fever of 102.5 with measle like rash all over body - went to PCP.
pt reports fever, body aches, nausea, fatigue and diarrhea approximately 24 hours after injection.  drinking fluids and taking tylenol to help with symptoms
Twelve and a half days after receiving the 3rd Moderna Covid Vax Booster in the evening of 12/2/21, I experienced severe, acute urticaria covering 80% of by body on 12/15/21.   It began with hot feeling, flushed red, hives/pruritic and inflamed skin behind ears and neck and eventually covered 80% of my body from my scalp to my feet including on my face.  This lasted for over two weeks and has very gradually subsided.  It has not completely disappeared as of this writing.  The itching and redness was very severe and I was unable to go to work, fully dress, etc. during most of this time.  During this time, I visited my Internist, a Dermatologist and finally an Allergist/Immunologist who theorized that I experienced a delayed onset reaction from the Moderna Covid Booster since the reaction occurred within two weeks of receiving the booster.
pt recvd vax & 2MAR93 3-4 days later noted lt arm inject site w/redness edema, inc soreness & red rasied areas just around site; clinic notified to put heat on site; 9MAR94 arm cont to hurt, inc swelling & muscle aching; t101.6;
6 y/o female child is referred from clinic regarding enlarging inflammatory lesion on left thigh 3 days after receipt of DTAP-IPV and HBV vaccines.
Patient stated that she had no reaction from the first vaccine. Patient stated that her air ways was cut off and her Lupus flared up and she ended up in the hospital. Patient received the booster shot and she had five days of loose stool and her air ways was closing. Her throat was closing up. Patient went to the Dr. on 9/8/21. DR. called 911 and sent her right to the ER.
This spontaneous report as received from a pharmacist refers to an unspecified number of patients of patients of unknown ages and genders. On an unknown date, the patients were vaccinated with ROTATEQ (dose, route and lot number were not reported), vaccine had been exposed to multiple excursions with highest temperature reaching 57F for total time of 206 hours and these vaccines' stability could not be supported. No adverse effects reported. This is one of several reports from the same source. Additional information has been requested.
Patient was given the incorrect vaccine and vaccine dosage. Patient was administered Pfizer 5-11years undiluted, in the right deltoid. Patient PCP notified, patient was observed for 30 minutes, in addition, the patient was observed for one (1) hour in the waiting area. . The patient did not have any complaints at this time. The paitient PCP observed and spoke with the patient  and told her she was given Pfizer pediactric dose insted of Moderna and reccommended that she wait at the clinic until we obtain additonal information from Pfizer. Pfizer medical was called  and the reccomendation was: Do not repeat the COVID Vaccine.  Patient was given information. Patient left with no negative reactions at that time.
drowsiness; extra dose administered; This case was reported by a pharmacist via call center representative and described the occurrence of drowsiness in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis and Herpes zoster (Shingrix) (batch number 9LG54, expiry date 25th September 2021) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On 27th March 2019, the patient received the 2nd dose of Shingrix. On 26th June 2019, the patient received the 3rd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, less than a year after receiving Shingrix and less than a day after receiving Shingrix, the patient experienced drowsiness and extra dose administered. On an unknown date, the outcome of the drowsiness and extra dose administered were unknown.   It was unknown if the reporter considered the drowsiness to be related to Shingrix, Shingrix and Shingrix.  Additional details were provided as follows: The age at vaccination for 1st dose was not reported. The patient was potentially given a 3rd dose of Shingrix.  The reporter stated that they were not sure if the patient received 3 doses. They could only verify 2 given at their location. No additional information was given. It was not clear after which dose drowsiness was occurred hence all 3 doses of Shingrix were considered as suspects. The vaccination date of the 3rd dose was reported as 26th June 2016 but, it seems to be typhographical error so we have changed it to 26th June 2019.
ACHY BONES; GENERAL  MALAISE; NAUSEA; FEVER; HEADACHE; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported. On 14-MAR-2021, the subject experienced achy bones. On 14-MAR-2021, the subject experienced general malaise. On 14-MAR-2021, the subject experienced nausea. On 14-MAR-2021, the subject experienced fever. On 14-MAR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the general malaise, nausea, fever, achy bones and headache was not reported. This report was non-serious.
Side effect is trying to report; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Side effect is trying to report) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no adverse event reported).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (Side effect is trying to report). At the time of the report, ADVERSE EVENT (Side effect is trying to report) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Had HPV #3 4/9/13 - woke up 2AM with headache, fever, dizzy, nausea. Pt. seen in office, symptoms resolving.
Student received H1N1 vaccine at 11:00am and at 11:20 child fainted and vomited 911 called.
Precipitous rise in blood pressure; anxiousness; lightheadedness; generalized discomfort.
On 7/10/2022 I had a scratchy throat that Sunday night. The next day Monday morning at 6:00AM I felt terrible and test positive for COVID-19. I had a scratchy throat, a lot of coughing, a runny nose, and a major sore throat. It felt like a very severe cold. I called my doctor and he told me to go to the ER. They put me on a prescription for molnupiravir. My temperature today is at about 98 degrees. The cough is still there, and sometimes I cough so badly that it gets hard to breath. I have a stuffy nose, and it drips sometimes. I am better than I was on Monday, but I am still not fully recovered.
This spontaneous report was received from a physician and a medical assistant and refers to a currently 19-year-old male patient. The patient had no specific pertinent medical history, no concomitant medications, no known drug allergies. On an unknown date, in childhood, the patient was vaccinated with M-M-R II (lot#, dose, frequency and route of administration were not reported). It was believed the entire M-M-R II series were completed. The patient was seen in the office at unspecified time in recent past (date unknown) as there was an unspecified "outbreak" in community and the patient was verifying immunity, his antibody level for mumps showed "low". It was reported that the patient received measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) on 02-JAN-2019 for the treatment of low antibody to M-M-R II mumps component. The outcome of low antibody level for mumps was reported as not recovered. Causality assessment was not provided.
Pt recv vax on 10/26/98; on10/27/98 pt exp rx at Lt leg vax site of red, swelling, warm; tx=Tylenol, warm compress, warm water, Benadryl cream
Booster dose was given in less than 6 months after second dose; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Booster dose was given in less than 6 months after second dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 27-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Dec-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Booster dose was given in less than 6 months after second dose). On 15-Dec-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Booster dose was given in less than 6 months after second dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Treatment information was  not reported.    This case was linked to MOD-2021-418062 (Patient Link).
Left deltoid and bicep have been intermittent itchy and a dull deep pain that comes and goes at the injection sites. Constantly occurs almost every day several times a day.
Had a sharp pain in left temple around 9 pm Thursday night that lasted over 30 minutes. Had several more over night  along with joint pain; after one more in the morning went to the ER thinking I could have an aneurysm.  ER doctor ordered  bloodwork and tested for Lymes and rheumatoid arthritis in addition to cat scan. All negative so she concluded it could be Shingles. She prescribed valacyclovir and Gabapentin for 7 days.
i had shingles in left side a month prior to vaccine that healed.  I then got vaccine in right arm and a few days later got shingles out break even worse than the first one but this time in the right side.  I still have them and have been on 2 courses of valtrex and they are not resolving.  i am not having to take valtrex daily and was told it could be for a year as my immune system is weakened since the vaccine.  i am not able to get the 2nd vaccine.
Patient received vaccination at approx. 14:10. Started feeling throat tightness and burning. Given Benadryl 50mg orally. At 15:00, stated throat felt better. EMS called to site. Transferred care to EMS and denied transfer to ED.
This spontaneous report as received from a pharmacist refers to a 67 years old female patient with high cholesterol. The patient had no drug reactions/allergies. On 14-JUN-2013 the patient was vaccinated with a 0.65 ml dose of ZOSTAVAX (lot # H018510, expiration date: 15-JAN-2014), subcutaneous injection at unspecified location. Concomitant therapy included with pravastatin. Within 24 hours of receiving date (14-JUN-2013), the patient developed an injection site reaction of redness, swelling and bruising after the vaccination. The patient had sought medical attention via contacted pharmacy. Non lab diagnostics studies performed. No treatment was given for the events. Currently the patient had no more redness and swelling but she had a bruise at the injection site. Additional information has been requested.
Patient received zoster vaccine right triceps on 3/28/07, on 3/29/07 awakened with swollen hand, then developed blister without redness. (No bruising at injection site or down the arm)
On 4/8/2021 SM received the Moderna COVID vaccination in her left arm. The vaccination administration was instantly painful and didn't feel like it was in the right place per patient. Pt suffered from intense shoulder pain to the point where she was having difficulty sleeping with it for 4 days following the vaccination. She was having painful range of motion and a grinding sensation in her joint.
allergic reaction; big bumps; itchy at the back; This is a spontaneous report from a Pfizer sponsored program. This contactable consumer (patient's son) reported for a female patient (reporter's mother). A female patient of an unspecified age received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection), dose 2 via an unspecified route of administration on 25Apr2021 (Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient previously took first dose of bnt162b2 on an unspecified date for covid-19 immunisation. The patient experienced allergic reaction with big bumps and itchy at the back on an unspecified date. Outcome of all events were unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
no adverse event; a 14 month old patient received an expired dose of VARIVAX; This spontaneous report was received from an office manager via company representative and refers to a 14-month-old patient of an unknown gender. There was no information about the patient's concurrent condition, concomitant medication and medical history provided. On 30-SEP-2021, the patient was vaccinated with an expired dose of varicella virus vaccine live (oka/merck)(VARIVAX) first dose for prophylaxis (exact dose, route of administration and lot number were not provided) (expired vaccine used). No additional adverse event (AE) was reported.
My husband was vaccinated with the Covid-19 Booster vaccine manufactured by Pfizer on 8/18/2021.  He was vaccinated at the Pharmacy, 02346.    On the morning of 8/20/21, he presented with symptoms of stroke: Lt sided paralysis, vision loss, difficulty swallowing, difficulty speaking, bladder and bowel incontinence.  He was transported by ambulance to Hospital in, where an ischemic stroke diagnosis was confirmed by CT scan.  At that time he was treated with anticoagulation medicine and immediately transferred to Hospital where he spent two weeks after treatment by thrombectomy to remove the clot in his brain.  He subsequently had a bleed in his brain.
Patient has a "red splotch" at the site of his MCV injection. Shortly after vaccination was administered on 3/7/17, the arm appeared red and became itchy. There is a black dot where the injection pierced the skin. On 3/9 in the evening the area of redness was 3-4" in diameter and mom gave BENADRYL then as well as in the AM of 3/10 because patient was c/o itching.
went in and out of consciousness, RN reported dry heaving and throat tightness. was sent to the hospital ED for further evaluation
Very tired, slept longer than normal. A little out of sorts. Big red spot around where injection occurred, about 1 or 2 inches by 3 or 4 inches. (not a wet). Very Slight fever.
She had Covid 19 virus symptoms; shortness of breath; heart is racing; chills; she feels her mouth as if she had eaten too much salt; diarrhea; Feet pain; This is a spontaneous report from a contactable consumer or other non-HCP. A 59-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EW0170), via an unspecified route of administration, administered on Left Arm on 14May2021 09:00 at single dose for covid-19 immunization (to protect herself from the virus). The patient's Medical history and concomitant medications were not reported. The Family Medical History Relevant to events was reported as none. The patient has not received any other vaccinations within four weeks prior to the first administration date of the suspect vaccine. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EW0172) via unspecified route of administration administered on Left Arm on 23Apr2021 for COVID-19 immunization. On 14May2021 14:00 the patient experienced shortness of breath, heart is racing, chills, she feels her mouth as if she had eaten too much salt, diarrhea, feet pain. Upon received follow-up information on 20May2021, it was reported that On 18May2021 the patient experienced She was told she had Covid 19 virus symptoms and if her symptoms persisted to keep treating herself at home. The doctor did not perform a Covid 19 virus test. It was reported that About 5 hours after receiving her second Covid 19 vaccine, the patient experienced the events. The events resulted in physician visit. The relevant tests was reported as none. The outcome of event she had covid 19 virus symptoms was unknown, while rest of events was not recovered.  Follow up(20May2021): New Information received from the Pfizer colleague includes new adverse event details, anatomical location of both doses details.  Follow up(20May2021): Upon follow up, no new information has been included.  Information about Lot/Batch number is available. Further information is expected.
9/19/12 dizziness, vomiting, weakness x 2-3 days. No tx given. Pt did report symptoms. 10/17/12 dizziness, vomiting, weakness x 2-3 days. No tx given, pt. did not report symptoms.
EXTREME DIZZINESS.  FELL TO GROUND.  NON-RESPONSIVE FOR A COUPLE MINUTES.
fever to 101.5, fussiness, copious amounts clear salvia-interfered w/eating 22FEB98;23FEB98 excessive but not as bad 22FEB98 fever, fussiness;
ADMINISTRATION OF EXPIRED VACCINE; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 24-SEP-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot number. No concomitant medications were reported.  On 24-SEP-2021, the patient experienced administration of expired vaccine. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The outcome of administration of expired vaccine was not reported. This report was non-serious.
Hard bump started 03/29/11. Redness & warm started 03/29/11 and has increased in size, sore all time 5 on (0 to 10 scale).